Abstract

Pursuant to Article L. 5122-6 of the Public Health Code, the High Council for Public Health has determined the minimum information required to advertise the quadrivalent vaccine diphtheria-tetanus-pertussis-polio Repevax®. Source: http://www.hcsp.fr/docspdf/avisrapports/hcspa20100528_mmo_Repevax.pdf

  • Europe
  • France
  • health policy
  • poliomyelitis
  • Diphtheria
  • Tetanus
  • Poliomyelitis
  • Pertussis